Notification

All renewing DEA-registered practitioners must complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders by their next scheduled DEA registration submission on or after June 27, 2023. Learn More

stethoscope on top of books with DEA Required badge

DEA MATE Act Required 8-Hour Training for License Renewal

Meet the DEA's new requirement under the Medication Access and Training Expansion (MATE) Act in an online, high-quality and self-paced 8-hour DEA MATE Act course specifically designed for practitioners, including Physicians, PAs, NPs, Pharmacists, Dentists and others.

Learn More
  • Foundations in Opioid Administration: Micro-Certification

  • Opioids and Pain Management: Micro-Certification

  • Opioid Misuse: Micro-Certification

  • Substance Use Disorder: Opioids, Treatment Approaches, and Relapse

  • confidentiality of substance use patient records

    Confidentiality of Substance Use Patient Records

Course Objectives

After completion of this course, the participant should be able to:

  • Recall legal requirements for opioid prescribing and handling.
  • Apply key recommendations and best practices, restrictions, and requirements for prescribing opioids for pain management.
  • Specify essential client education and conversations related to use of opioids for pain management, including safety, storage, and disposal information.
  • Identify how geographic, ethnic, and socioeconomic health disparities and biases affect appropriate and equitable pain assessment, treatment, and management.
  • Identify the best use of screening tools for substance use disorder (SUD).
  • Describe how to identify risk for, diagnose, and appropriately treat someone with opioid overdose, opioid use disorder (OUD), or SUD.
  • Evaluate the process and functions of state Prescription Drug Monitoring Programs (PDMPs).
  • Identify techniques for building mutual respect between the client, family, and care team responsible for treatment of OUD or SUD.
  • Explain potential treatment benefits and pitfalls of medication-assisted treatment (MAT) programs to treat OUD or SUD.
  • List strategies that align with HIPAA or the 42 CFR Part 2 (Final Rule) for maintaining the confidentiality of clients and their protected health information (PHI) while undergoing treatment for OUD or SUD.

Accreditation

HealthStream designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational offering is provided by HealthStream CNE Provider Unit. HealthStream CNE Provider Unit is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. ANCC Provider Number: P0088. This activity is awarded 8.0 contact hours; 0.0 contact hours are in pharmacology.

TRUSTED HEALTHCARE EDUCATION PROVIDER

HealthStream is the leading provider of clinical development solutions for healthcare professionals and the healthcare industry.

HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations' greatest asset: their people. To learn more, please visit healthstream.com.

Our Top FAQs

How can I access my courses/content?

Once you have completed your purchase, look for an email requesting you set up login credentials. The email will contain a unique link to set up a new hStream ID using the address you provided.

If you already have an hStream ID using this email address, you do not have to create new login credentials and can begin accessing your new subscription.

How can I find my transcript or find evidence of completed courses?

You will have access to transcripts through the HealthStream Learning Center (HLC).

How do I contact support?

For additional assistance please email customer support at cmestoresupport@healthstream.com a representative will be in touch.